Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 4, 2009, Pages 329-335

  Chang, En Pen ^a   Chiang, Dung Hung ^b   Lin, Mei Lin ^b   Chen, Te Li ^b,c   Wang, Fu Der ^b   Liu, Cheng Yi ^b  

^a Wei Gong Memorial General Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bacteremia; Enterobacter aerogenes; Mortality; Risk factors

Indexed keywords

CEPHALOSPORIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; APACHE; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL FEATURE; COMORBIDITY; DISEASE SEVERITY; ENTEROBACTER AEROGENES; FEMALE; FEVER; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PNEUMONIA; RETROSPECTIVE STUDY; TAIWAN;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; APACHE; BACTEREMIA; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TAIWAN; TREATMENT OUTCOME; YOUNG ADULT;

EID: 74849085510     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Sanders WE Jr, Sanders CC. Enterobacter spp: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev. 1997;10:220-41.
2. Blot SI, Vandewoude KH, Colardyn FA. Evalution of outcome in critically ill patients with nosocomial Enterobacter bacteremia: results of a matched cohort study. Chest 2003;123:1208-13.
3. Donnenberg MS. Enterobacteriaceae. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th ed. Philadelphia: Churchill Livingstone; 2005:2579.
4. Ristuccia PA, Cunha BA. Enterobacter. Infect Control. 1985;6:124-8.
5. Walker KE, Horneman AJ. Enterobacteriaceae. In: Mahon CR, Lehman DC, eds. Textbook of diagnostic microbiology. 3rd ed. Philadelphia: Elsevier Inc Press; 2007:513-4.
6. Russo TA. Disease cause by Gram-negative enteric bacilli. In: Kasper DL, Braunwald E, eds. Harrison's principle of internal medicine. 16th ed. New York: McGraw-Hill Companies, Inc Press; 2005:883-4.
7. Edwards KE, Allen JR, Miller MJ, Yogev R, Hoffman PC, Klotz R, et al. Enterobocter aerogenes primary bacteremia in pediatric patients. Pediatrics. 1978;62:304-6.
8. Loiwal V, Kumar A, Gupta P, Gomber S, Ramachandran VG. Enterobacter aerogenes outbreak in a neonatal intensive care unit. Pediatr Int. 1999;41:157-61.
9. Palmer DL, Kuritsky JN, Lapham SC, King RM, Akl BF. Enterobacter mediastinitis following cardiac surgery. Infect Control. 1985;6:115-9.
10. Michowitz NH, Berger SA, Chayen D. Crepitant cellulitis due to Enterobacter aerogenes. Isr J Med Sci. 1985;21:546-7.
11. Haddy RI, Cecil ML, Norris LL, Markert RJ. Enterobacter bacteremia in the community hospital. J Fam Pract. 1991;32:601-6.
12. Bouza E, Garcia de la Torre M, Erice A, Loza E, Diaz-Borrego JM, Buzon L. Enterobacter bacteremia. An analysis of 50 episodes. Arch Intern Med. 1985;145:1024-7.
13. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, et al. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis. 2004;39:812-8.
14. Performance standards for antimicrobial disk susceptibility tests. Approved standard, and M2-A9. 9th ed. Wayne: Clinical and Laboratory Standards Institute; 2006.
15. Dahmash NS, Chowdhury NH, Fayed DF. Septic shock in critically ill patients: aetiology, management and outcome. J Infect. 1993;26:159-70.
16. Regner KR, Connally HM, Schaff HV, Albright RC. Acute renal failure after cardiac surgery for carcinoid heart disease: incidence, risk factors, and prognosis. Am J Kidney Dis. 2005;45:826-32.
17. Bauer C, Melamed ML, Hostetter TH. Staging of chronic kidney disease: time for a course correction. J Am Soc Nephrol. 2008;19:844-6.
18. Raad II, Bodey GP. Infectious complications of indwelling vascular catheters. Clin Infect Dis. 1992;15:197-208.
19. Valero C, Garcia Palomo JD, Matorras P, Fernandez-Mazarrasa C, Gonzalez Fernandez C, Farinas MC. Acinetobacter bacteraemia in a teaching hospital, 1989-1998. Eur J Intern Med. 2001;12:425-9.
20. Bodey GP, Elting LS, Rodriguez S. Bacteremia caused by Enterobacter: 15 years of experience in a cancer hospital. Rev Infect Dis. 1991;13:550-8.
21. Lin YC, Chen TL, Ju HL, Chen HS, Wang FD, Yu KW, et al. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia. J Microbiol Immunol Infect. 2006;39:67-72.
22. Fluit AC. Towards more virulent and antibiotic-resistant Salmonella? FEMS Immunol Med Microbiol. 2005;43:1-11.
23. Korfmann G, Wiedemann B. Genetic control of beta-lactamase production in Enterobacter cloacae. Rev Infect Dis. 1988;10:793-9.
24. Olson B, Weinstein RA, Nathan C, Kabins SA. Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother. 1983;11:299-310.
25. Huber TW, Thomas JS. Detection of resistance due to inducible beta-lactamase in Enterobacter aerogenes and Enterobacter cloacae. J Clin Microbiol. 1994;32:2481-6.
26. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991;115:585-90.
27. Shlaes DM. The clinical relevance of Enterobacter infections. Clin Ther. 1993;15:21-8.
28. Kaye KS, Cosgrove S. Harris A, Eliopoulos GM, Carmeli Y. Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother. 2001;45:2628-30.
29. Lee SO, Kim YS, Kim BN, Kim MN, Woo JH, Ryu J. Impact of previous use of antibiotics on development of resistance to extended-spectrum cephalosporins in patients with Enterobacter bacteremia. Eur J Clin Microbiol Infect Dis. 2002;21:577-81.
30. Reny JL, Vuagnat A, Ract C, Benoit MO, Safar M, Fagon JY. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med. 2002; 30:529-35.
31. Lobo SM, Lobo FR, Bota DP, Lopes-Ferreira F, Soliman HM, Melot C, et al. C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest. 2003;123:2043-9.
32. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703.
33. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg. 2003;237:319-34.